251 related articles for article (PubMed ID: 15207021)
1. Epidermal growth factor receptor as a therapeutic target for the treatment of colorectal cancer.
Amador ML; Hidalgo M
Clin Colorectal Cancer; 2004 May; 4(1):51-62. PubMed ID: 15207021
[TBL] [Abstract][Full Text] [Related]
2. Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer.
Snyder LC; Astsaturov I; Weiner LM
Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S71-80. PubMed ID: 16336752
[TBL] [Abstract][Full Text] [Related]
3. Current status of small-molecule tyrosine kinase inhibitors targeting epidermal growth factor receptor in colorectal cancer.
Kuo T; Fisher GA
Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S62-70. PubMed ID: 16336751
[TBL] [Abstract][Full Text] [Related]
4. The role of the epidermal growth factor receptor in the treatment of colorectal carcinoma.
Waxman ES; Herbst RS
Semin Oncol Nurs; 2002 May; 18(2 Suppl 2):20-9. PubMed ID: 12053861
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
Efferth T
Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
[TBL] [Abstract][Full Text] [Related]
6. The role of epidermal growth factor receptor-targeted antibody therapy in previously treated colorectal cancer.
Watkins D; Cunningham D
Clin Colorectal Cancer; 2007 Oct; 6 Suppl 2():S47-52. PubMed ID: 18021487
[TBL] [Abstract][Full Text] [Related]
7. Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
Kendall A; Lord R; Maisey N
Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):142-51. PubMed ID: 19954416
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directions.
Starling N; Cunningham D
Curr Opin Oncol; 2004 Jul; 16(4):385-90. PubMed ID: 15187895
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor-targeted therapy in colorectal cancer.
O'dwyer PJ; Benson AB
Semin Oncol; 2002 Oct; 29(5 Suppl 14):10-7. PubMed ID: 12422309
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor: pathway, therapies, and pipeline.
Goffin JR; Zbuk K
Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives.
Spano JP; Fagard R; Soria JC; Rixe O; Khayat D; Milano G
Ann Oncol; 2005 Feb; 16(2):189-94. PubMed ID: 15668269
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: Potential impact in colorectal cancer.
De Pauw I; Wouters A; Van den Bossche J; Peeters M; Pauwels P; Deschoolmeester V; Vermorken JB; Lardon F
Pharmacol Ther; 2016 Oct; 166():71-83. PubMed ID: 27373506
[TBL] [Abstract][Full Text] [Related]
13. Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients.
Ruzzo A; Graziano F; Canestrari E; Magnani M
Curr Cancer Drug Targets; 2010 Feb; 10(1):68-79. PubMed ID: 20088793
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor as a target for chemotherapy.
Vallbohmer D; Lenz HJ
Clin Colorectal Cancer; 2005 Apr; 5 Suppl 1():S19-27. PubMed ID: 15871762
[TBL] [Abstract][Full Text] [Related]
15. Targeting EGFR in pancreatic cancer treatment.
Troiani T; Martinelli E; Capasso A; Morgillo F; Orditura M; De Vita F; Ciardiello F
Curr Drug Targets; 2012 Jun; 13(6):802-10. PubMed ID: 22458527
[TBL] [Abstract][Full Text] [Related]
16. The epidermal growth factor receptor as a target for gastrointestinal cancer therapy.
Tedesco KL; Lockhart AC; Berlin JD
Curr Treat Options Oncol; 2004 Oct; 5(5):393-403. PubMed ID: 15341677
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?
Ponz-Sarvisé M; Rodríguez J; Viudez A; Chopitea A; Calvo A; García-Foncillas J; Gil-Bazo I
World J Gastroenterol; 2007 Nov; 13(44):5877-87. PubMed ID: 17990353
[TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor receptor as a target for colorectal cancer therapy.
Lockhart AC; Berlin JD
Semin Oncol; 2005 Feb; 32(1):52-60. PubMed ID: 15726506
[TBL] [Abstract][Full Text] [Related]
19. EGFR-targeted therapies in colorectal cancer.
Overman MJ; Hoff PM
Dis Colon Rectum; 2007 Aug; 50(8):1259-70. PubMed ID: 17566832
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies.
Zhang W; Gordon M; Lenz HJ
Ann Med; 2006; 38(8):545-51. PubMed ID: 17438669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
